BUY Lupin Limited — Deven Choksey, DRChoksey
byDeven Choksey, DRChokseyHorizon: NA (inferred 1 year)13 Nov 2025via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Lupin Limited has received approval from the U.S. Food and Drug Administration (FDA) for its Glycerol Phenylbutyrate Oral Liquid.
BSE · Company Update·5 May · yesterday
2 advisors have active short-term BUY calls on this stock, with 1 issued in the last 14 days
Advisor consensus · adjacent horizon·4 May · yesterday
Lupin Limited has launched Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets in the United States.
BSE · Company Update·22 Apr · 2w ago
3 other SEBI-registered advisors have active long-term BUY calls on this stock
Advisor consensus · same horizon·16 Feb · 3mo ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Lupin
- BUY — Aditya Agarwal, Coheron Brokers22 Oct 2026 · ~2 weeks · target ₹2,100 · Active
- BUY — Rajesh Satpute16 Oct 2026 · Same day · target ₹2,035 · Expired
- BUY — Sumeet Bagadia, Choice Broking29 Sept 2026 · ~2 weeks · target ₹2,150 · Expired
- BUY — Jigar S Patel, Anand Rathi28 Sept 2026 · ~3 months · target ₹2,300 · SL hit
- BUY — Siddharth Rai Mangala22 Sept 2026 · Same day · target ₹2,160 · Expired
More from Deven Choksey, DRChoksey
- BUY ICICI Bank21 Oct 2026 · ~1 year · target ₹1,847 · Active
- BUY HDFC Bank21 Oct 2026 · ~1 year · target ₹981 · Active
- BUY Axis Bank21 Oct 2026 · ~1 year · target ₹1,507 · Active
- BUY Bajaj Housing Finance21 Oct 2026 · ~1 year · target ₹110 · Active
- SELL Tata Technologies16 Oct 2026 · ~1 year · target ₹700 · Target hit

